CTOR vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

CTOR

51.0
AI Score
VS
CTOR Wins

CRON

38.8
AI Score

Investment Advisor Scores

CTOR

51score
Recommendation
HOLD

CRON

39score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric CTOR CRON Winner
Forward P/E 5.8207 20.8768 CTOR
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 58.4% CRON
Earnings Growth 0.0% 126.8% CRON
Tradestie Score 51.0/100 38.8/100 CTOR
Profit Margin 0.0% 39.1% CRON
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

CTOR 1M: -23.1% · 3M: -22.5% CRON 1M: +5.6% · 3M: +7.3%

Current Technical Phase

CTOR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.7%), weak momentum, RSI 42

RSI (14): 42.3 · Price: $0.57

CRON

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.6 · Price: $3.38

Fundamentals Snapshot

Metric CTOR CRON
Market Cap — —
Forward P/E -3.0 13.3
Trailing P/E — 21.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.7%
Gross Margin 0.7% 0.5%
Operating Margin -6.7% 0.1%
EPS -0.51 0.16
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CTOR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.